The Neuroprotective Marine Compound Psammaplysene A Binds the RNA-Binding Protein HNRNPK

Mar Drugs. 2017 Aug 7;15(8):246. doi: 10.3390/md15080246.

Abstract

In previous work, we characterized the strong neuroprotective properties of the marine compound Psammaplysene A (PA) in in vitro and in vivo models of neurodegeneration. Based on its strong neuroprotective activity, the current work attempts to identify the physical target of PA to gain mechanistic insight into its molecular action. Two distinct methods, used in parallel, to purify protein-binding partners of PA led to the identification of HNRNPK as a direct target of PA. Based on surface plasmon resonance, we find that the binding of PA to HNRNPK is RNA-dependent. These findings suggest a role for HNRNPK-dependent processes in neurodegeneration/neuroprotection, and warrant further study of HNRNPK in this context.

Keywords: HNRNPK; Psammaplysene A; RNA metabolism; foxo; neurodegeneration.

MeSH terms

  • HEK293 Cells
  • Heterogeneous-Nuclear Ribonucleoprotein K / metabolism*
  • Humans
  • Marine Biology
  • Neuroprotective Agents / pharmacology*
  • Protein Binding
  • RNA-Binding Proteins / metabolism*
  • Tyrosine / analogs & derivatives*
  • Tyrosine / pharmacology

Substances

  • Heterogeneous-Nuclear Ribonucleoprotein K
  • Neuroprotective Agents
  • RNA-Binding Proteins
  • psammaplysene A
  • HNRNPK protein, human
  • Tyrosine